-+ 0.00%
-+ 0.00%
-+ 0.00%

24/7 MARKET NEWS: LIXTE BIOTECH ADVANCES PRECISION ONCOLOGY PIPELINE WITH FIRST PHASE 1B/2 TRIAL READOUT EXPECTED IN 2H 2025

Reuters·08/15/2025 01:06:09

Please log in to view news